CD3E and neoplasm: Although bsTCE with high affinity (KD < 1 nM) to CD3ε exhibited outstanding in vitro efficacy, those with a lower affinity (KD of 50–200 nM) minimized CD3-mediated plasma clearance or trapping of spleen and lymph nodes, showed efficient tumor distribution in vivo [114,115,116,117].